Heparin‐induced thrombocytopenia (HIT) is a serious drug reaction that leads to a decrease
in platelet count and a high risk of thrombosis. HIT patients produce pathogenic …

Heparin‐induced thrombocytopenia (HIT) is an immune reaction to heparin. It often causes
severe thrombosis which may lead to limb gangrene and thrombosis‐associated death. The …

Heparin induced thrombocytopenia (HIT) remains the most severe adverse effect of heparin
therapy. Recently, new information has been uncovered regarding the pathogenesis of this …

Heparin-induced thrombocytopenia (HIT) type II is an immune-mediated reaction that
generally occurs 5 to 14 days after initiation of heparin therapy. It is characterized by a …

Heparin induced thrombocytopenia (HIT) is a severe complication of heparin therapy. It is
generally accompanied by a paradoxical decrease in platelets leading to activation of …

Heparin‐induced thrombocytopenia (HIT) is characterized by the presence of an antibody
which can activate platelets in the presence of heparin. The in vitro Ca2+ mobilization …

Heparin-induced thrombocytopenia (HIT), the most common complication of heparin
therapy, is also the most common form of the drug-induced thrombocytopenias. HIT is …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated disorder caused by the
development of antibodies to platelet factor 4 (PF4) and heparin. The thrombocytopenia is …

Heparin-induced thrombocytopenia (HIT) is the most important immunological drug reaction
that patients face today. HIT typically develops in patients 5 days after starting heparin …

In the past two decades there has been significant improvement in its diagnosis and
treatment (1, 4). HIT is a hypersensitivity reaction to unfractionated heparin (UFH) and low …